The Gsdme KO mice have a C57BL/6N background, which has an incidence of colon adenocarcinomas of ~50%, with 1.0 ± 1.2 lesions per mouse after treatment with AOM and dextran sodium sulfate (DSS), by 23 weeks of age [36]. This evidence concerns the gene GSDME and colon adenocarcinoma.